{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:23:22Z","timestamp":1792686202407,"version":"4.5.0"},"reference-count":18,"publisher":"Georg Thieme Verlag KG","issue":"CP","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Science and Technology, Taiwan","award":["NMRPD10Q041"],"award-info":[{"award-number":["NMRPD10Q041"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TH Open"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Background and Aims Current guidelines advocate for indefinite direct oral anticoagulant (DOAC) therapy after successful catheter ablation for atrial fibrillation (AF), based on the CHA2DS2-VASc score. This strategy is challenged by the inherent bleeding risk of DOAC versus the potentially reduced stroke risk post-ablation. We aimed to compare long-term antithrombotic strategies in patients with durable freedom from AF recurrence.<\/jats:p>\n                  <jats:p>Methods We conducted a meta-analysis of the ALONE-AF and OCEAN trials enrolling 2124 patients with no documented AF recurrence for \u22651 year after ablation. The trials compared DOAC continuation versus DOAC discontinuation. We calculated pooled risk ratios (RRs) with 95% confidence intervals (CIs) for primary efficacy (thromboembolic events\/all-cause mortality) and safety (bleeding events) outcomes.<\/jats:p>\n                  <jats:p>Results The meta-analysis found no statistically significant difference between DOAC continuation and DOAC discontinuation for all stroke or systemic embolism (RR 1.36; 95% CI: 0.16\u201311.38), transient ischemic attack (RR 0.20; 95% CI: 0.03\u20131.15), myocardial infarction (RR 0.08; 95% CI: 0.00\u20131.37), and all-cause mortality (RR 1.43; 95% CI: 0.55\u20133.74). In contrast, DOAC continuation was associated with a significantly higher risk of major bleeding (RR 3.07; 95% CI: 1.05\u20138.96) and clinically relevant non-major bleeding (RR 2.47; 95% CI: 1.01\u20136.00). Subgroup analysis confirmed consistent treatment effects.<\/jats:p>\n                  <jats:p>Conclusion In patients who achieve durable freedom from AF recurrence for at least 1 year following catheter ablation, the absolute risk of thromboembolic events was very low. Strategies involving the discontinuation of DOACs were associated with a statistically lower risk of bleeding without significant risk of stroke.<\/jats:p>","DOI":"10.1055\/a-2916-8912","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T23:20:37Z","timestamp":1784589637000},"source":"Crossref","is-referenced-by-count":1,"special_numbering":"S","title":["Antithrombotic Management after Successful Catheter Ablation for Atrial Fibrillation: Meta-analysis of the ALONE-AF and OCEAN Trials"],"prefix":"10.1055","volume":"10","author":[{"given":"Wen-Han","family":"Cheng","sequence":"first","affiliation":[{"name":"National Yang Ming Chiao Tung University Hospital, Taiwan Province, Taiwan","place":["Yilan"],"department":["Department of Internal Medicine, Division of Cardiology"]},{"name":"Cardiovascular Center, Taipei Veterans General Hospital, Taipei City, Taiwan","place":["Taipei City"]},{"name":"Institute of Clinical Medicine and Cardiovascular Research Center, National Yang Ming Chiao Tung University, Taipei City, Taiwan","place":["Taipei City"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hsin","family":"Chan","sequence":"first","affiliation":[{"name":"Chang Gung Memorial Hospital Linkou, Taoyuan City, Taiwan","place":["Taoyuan"],"department":["Department of Cardiovascular"]},{"name":"College of Medicine, Chang Gung University, Taoyuan City, Taiwan","place":["Taoyuan"]},{"name":"School of Traditional Chinese Medicine, Chang Gung University, Taoyuan City, Taiwan","place":["Taoyuan"]},{"name":"Microscopy Core Laboratory, Chang Gung Memorial Hospital Linkou, Taoyuan City, Taiwan","place":["Taoyuan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Kuo","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Taipei Veterans General Hospital, Taipei City, Taiwan","place":["Taipei City"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo-Nan","family":"Liao","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Taipei Veterans General Hospital, Taipei City, Taiwan","place":["Taipei City"]},{"name":"Institute of Clinical Medicine and Cardiovascular Research Center, National Yang Ming Chiao Tung University, Taipei City, Taiwan","place":["Taipei City"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Min","family":"Liu","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Taipei Veterans General Hospital, Taipei City, Taiwan","place":["Taipei City"]},{"name":"Institute of Clinical Medicine and Cardiovascular Research Center, National Yang Ming Chiao Tung University, Taipei City, Taiwan","place":["Taipei City"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyoug","family":"Joung","sequence":"additional","affiliation":[{"name":"Severance Hospital, Yonsei University College of Medicine, Seoul, Korea (the Republic of)","place":["Seodaemun-gu"],"department":["Division of Cardiology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6587-3094","authenticated-orcid":false,"given":"Tze-Fan","family":"Chao","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Taipei Veterans General Hospital, Taipei City, Taiwan","place":["Taipei City"]},{"name":"Institute of Clinical Medicine and Cardiovascular Research Center, National Yang Ming Chiao Tung University, Taipei City, Taiwan","place":["Taipei City"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"issue":"01","key":"ref1","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"Peer Review Committee Members. 2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"J A Joglar","year":"2024","journal-title":"Circulation"},{"issue":"36","key":"ref2","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"ESC Scientific Document Group. 2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"I C Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"issue":"05","key":"ref3","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s10840-024-01771-5","article-title":"2024 European Heart Rhythm Association\/Heart Rhythm Society\/Asia Pacific Heart Rhythm Society\/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"67","author":"S Tzeis","year":"2024","journal-title":"J Interv Card Electrophysiol"},{"issue":"14","key":"ref4","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/jama.2025.14679","article-title":"ALONE-AF Investigators. Long-term anticoagulation discontinuation after catheter ablation for atrial fibrillation: the ALONE-AF randomized clinical trial","volume":"334","author":"D Kim","year":"2025","journal-title":"JAMA"},{"issue":"04","key":"ref5","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa2509688","article-title":"OCEAN Investigators. Antithrombotic therapy after successful catheter ablation for atrial fibrillation","volume":"394","author":"A Verma","year":"2026","journal-title":"N Engl J Med"},{"issue":"03","key":"ref6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1471-1842.2008.00827.x","article-title":"Retrieving randomized controlled trials from medline: a comparison of 38 published search filters","volume":"26","author":"K A McKibbon","year":"2009","journal-title":"Health Inf Libr J"},{"issue":"04","key":"ref7","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"G Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"13","key":"ref8","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/CIRCULATIONAHA.123.067512","article-title":"Direct oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation: a study-level meta-analysis of the NOAH-AFNET 6 and ARTESiA trials","volume":"149","author":"W F McIntyre","year":"2024","journal-title":"Circulation"},{"issue":"01","key":"ref9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/JCMA.0000000000000823","article-title":"Catheter ablation of atrial fibrillation in heart failure with impaired systolic function: an updated meta-analysis of randomized controlled trials","volume":"86","author":"T Y Chang","year":"2023","journal-title":"J Chin Med Assoc"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"d124","DOI":"10.1136\/bmj.d124","article-title":"Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study","volume":"342","author":"J B Olesen","year":"2011","journal-title":"BMJ"},{"issue":"10","key":"ref11","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.jacc.2023.06.029","article-title":"Ablation to reduce atrial fibrillation burden and improve outcomes. JACC Review Topic of the Week","volume":"82","author":"H T Schwennesen","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"ref12","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1056\/NEJMc2312837","article-title":"Anticoagulation with edoxaban in patients with atrial high-rate episodes","volume":"389","author":"N C Hsu","year":"2023","journal-title":"N Engl J Med"},{"issue":"02","key":"ref13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2310234","article-title":"ARTESIA Investigators. Apixaban for stroke prevention in subclinical atrial fibrillation","volume":"390","author":"J S Healey","year":"2024","journal-title":"N Engl J Med"},{"issue":"01","key":"ref14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12959-021-00322-6","article-title":"Bleeding risks with novel oral anticoagulants versus aspirin: a meta-analysis","volume":"19","author":"X Chen","year":"2021","journal-title":"Thromb J"},{"issue":"12","key":"ref15","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/jamacardio.2025.4151","article-title":"Major bleeding with apixaban vs aspirin: a subanalysis of the ARTESiA randomized clinical trial","volume":"10","author":"D M Siegal","year":"2025","journal-title":"JAMA Cardiol"},{"issue":"01","key":"ref16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.121.056109","article-title":"Influence of monitoring strategy on assessment of ablation success and postablation atrial fibrillation burden assessment: implications for practice and clinical trial design","volume":"145","author":"M Aguilar","year":"2022","journal-title":"Circulation"},{"issue":"02","key":"ref17","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jamainternmed.2013.1561","article-title":"Discerning the incidence of symptomatic and asymptomatic atrial fibrillation before and after catheter ablation (DISCERN AF): a prospective, multicenter study","volume":"173","author":"A Verma","year":"2013","journal-title":"JAMA Intern Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijcard.2020.02.001","article-title":"Expert opinion on continuous rhythm monitoring of patients with atrial fibrillation for candidates or patients who have already undergone ablation","volume":"305","author":"P Palmisano","year":"2020","journal-title":"Int J Cardiol"}],"container-title":["TH Open"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2916-8912.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:22:17Z","timestamp":1788564137000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2916-8912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":18,"journal-issue":{"issue":"CP","published-online":{"date-parts":[[2026,1,9]]},"published-print":{"date-parts":[[2026]]}},"alternative-id":["a29168912"],"URL":"https:\/\/doi.org\/10.1055\/a-2916-8912","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["2512-9465"],"issn-type":[{"value":"2512-9465","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7,20]]},"published":{"date-parts":[[2026,7,20]]}}}